Pre-programmed Tablet to Monitor Heart Rate
Mindful of the adage, prevention is better than cure, modern scientists have developed a novel e-health tool in the form of a pre-programmed tablet to monitor heart rate amongst patients. The research for this revolutionary tool, called the OPTILOGG, was released at the European Society of Cardiology’s meeting EuroHeartCare, in Sweden on May 20, 2017. It enables patients to manage their drug dosages to lower the rate of heart failure.
Heart failure is a common problem today, among people aged above 50 years. The event causes a failure in the pumping of the heart and this inconsistency in the pumping results in lack of blood flow to the different parts of the body. Lungs and abdominal parts start accumulating fluids, causing more fatigue and finally death. The rate of heart failure in patients aged 40-60 has increased exponentially leading to a growth in demand of the market for effective preventive measures.
Heart failure prevention measures mainly include drugs that can prevent fluid retention in the body by increasing the production of urine by the kidneys. These diuretic doses result in prevention of heart failure. However, it may be possible that these dosages may get higher and there may be a drastic weight loss or other symptoms can occur.
OPTILOGG reduces the chances of side effects of diuretics due to approximate dosage quantities. OPTILOGG is a simple pre-programmed tablet attached to a weighing scale that registers body weight and other symptoms and educates the patient about his overall condition.
In a recent study, 32 patients from primary care heart failure centres were taken into observation. More than 90% of the patients found the use OPTILOGG helpful. 31% of the patients were females and all the patients were above 65 years of age. The research determined that OPTILOGG can educate the patient about his own conditions so that the patient can decide the necessary treatment by themselves. The promising results of the primary studies have led to the implementation of OPTILOGG in all primary and specialised healthcare services across Europe.
You may be interested
Digital Health Market Expansion to be Persistent During 2026Albert R - October 12, 2018
"The Digital Health Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently released Digital Health Market research…
Medical Grade Hydrogel Market Poised to Take Off by 2026Albert R - October 12, 2018
"The Medical Grade Hydrogel Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently released Medical Grade Hydrogel…